Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer.

McAndrews KM, Xiao F, Chronopoulos A, LeBleu VS, Kugeratski FG, Kalluri R
Life Sci Alliance. 2021 Jul 19;4(9). pii: 4/9/e202000875. doi: 10.26508/lsa.202000875. Print 2021 Sep. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.